Rank | Gene Set | Z-score |
---|---|---|
1 | synaptic vesicle maturation (GO:0016188) | 6.00042200 |
2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.97643051 |
3 | synaptic vesicle exocytosis (GO:0016079) | 5.60088550 |
4 | glutamate secretion (GO:0014047) | 5.54853684 |
5 | locomotory exploration behavior (GO:0035641) | 5.50819310 |
6 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.30590101 |
7 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.25867616 |
8 | vocalization behavior (GO:0071625) | 5.14229517 |
9 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.13619074 |
10 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.91473842 |
11 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.90218453 |
12 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.69451570 |
13 | regulation of synaptic vesicle transport (GO:1902803) | 4.66288481 |
14 | neuronal action potential propagation (GO:0019227) | 4.63748471 |
15 | neurotransmitter secretion (GO:0007269) | 4.51046304 |
16 | exploration behavior (GO:0035640) | 4.46093435 |
17 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.41848788 |
18 | protein localization to synapse (GO:0035418) | 4.41246503 |
19 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.37128327 |
20 | layer formation in cerebral cortex (GO:0021819) | 4.31928013 |
21 | neuron cell-cell adhesion (GO:0007158) | 4.31596131 |
22 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.25162694 |
23 | cerebellar granule cell differentiation (GO:0021707) | 4.12686155 |
24 | L-amino acid import (GO:0043092) | 4.06433641 |
25 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.99779358 |
26 | proline transport (GO:0015824) | 3.98264596 |
27 | regulation of synapse structural plasticity (GO:0051823) | 3.90901492 |
28 | glutamate receptor signaling pathway (GO:0007215) | 3.90619113 |
29 | cellular potassium ion homeostasis (GO:0030007) | 3.83799583 |
30 | synaptic transmission, glutamatergic (GO:0035249) | 3.73705005 |
31 | activation of protein kinase A activity (GO:0034199) | 3.72063451 |
32 | dendritic spine morphogenesis (GO:0060997) | 3.70740407 |
33 | neuron-neuron synaptic transmission (GO:0007270) | 3.64908110 |
34 | neurotransmitter transport (GO:0006836) | 3.63897896 |
35 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.63770215 |
36 | gamma-aminobutyric acid transport (GO:0015812) | 3.61666805 |
37 | neuromuscular process controlling posture (GO:0050884) | 3.61288166 |
38 | synaptic vesicle endocytosis (GO:0048488) | 3.59697965 |
39 | sodium ion export (GO:0071436) | 3.58108816 |
40 | vesicle transport along microtubule (GO:0047496) | 3.57247291 |
41 | long-term memory (GO:0007616) | 3.54530619 |
42 | neuron recognition (GO:0008038) | 3.52402424 |
43 | amino acid import (GO:0043090) | 3.51726958 |
44 | cell communication involved in cardiac conduction (GO:0086065) | 3.43961742 |
45 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.43945540 |
46 | positive regulation of synapse maturation (GO:0090129) | 3.42971496 |
47 | regulation of synaptic plasticity (GO:0048167) | 3.42853804 |
48 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.38903579 |
49 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.38509256 |
50 | regulation of clathrin-mediated endocytosis (GO:2000369) | 3.36871684 |
51 | regulation of neurotransmitter levels (GO:0001505) | 3.36672557 |
52 | regulation of postsynaptic membrane potential (GO:0060078) | 3.35906951 |
53 | positive regulation of membrane potential (GO:0045838) | 3.31834527 |
54 | cellular sodium ion homeostasis (GO:0006883) | 3.31603876 |
55 | innervation (GO:0060384) | 3.31429002 |
56 | regulation of vesicle fusion (GO:0031338) | 3.30584091 |
57 | regulation of neurotransmitter secretion (GO:0046928) | 3.30374131 |
58 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.30023270 |
59 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.28634861 |
60 | long-term synaptic potentiation (GO:0060291) | 3.28332021 |
61 | axonal fasciculation (GO:0007413) | 3.27792181 |
62 | neuromuscular process controlling balance (GO:0050885) | 3.25805734 |
63 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.25637072 |
64 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.25578434 |
65 | potassium ion import (GO:0010107) | 3.25483836 |
66 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.25479522 |
67 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.23023125 |
68 | cell communication by electrical coupling (GO:0010644) | 3.20862220 |
69 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.17151007 |
70 | regulation of ARF protein signal transduction (GO:0032012) | 3.13986440 |
71 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.13927684 |
72 | organelle transport along microtubule (GO:0072384) | 3.09725516 |
73 | behavioral response to cocaine (GO:0048148) | 3.09168472 |
74 | response to auditory stimulus (GO:0010996) | 3.08823066 |
75 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.08637027 |
76 | intraspecies interaction between organisms (GO:0051703) | 3.08478705 |
77 | social behavior (GO:0035176) | 3.08478705 |
78 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.07679341 |
79 | establishment of nucleus localization (GO:0040023) | 3.06919474 |
80 | positive regulation of dendritic spine development (GO:0060999) | 3.06733122 |
81 | neuronal ion channel clustering (GO:0045161) | 3.05745839 |
82 | regulation of neurotransmitter transport (GO:0051588) | 3.03802015 |
83 | dendrite morphogenesis (GO:0048813) | 3.03389361 |
84 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.02554105 |
85 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.02193202 |
86 | establishment of synaptic vesicle localization (GO:0097480) | 3.02149150 |
87 | synaptic vesicle transport (GO:0048489) | 3.02149150 |
88 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.02028295 |
89 | regulation of dendritic spine development (GO:0060998) | 3.00746938 |
90 | positive regulation of neurotransmitter transport (GO:0051590) | 2.99966070 |
91 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.99397866 |
92 | response to pheromone (GO:0019236) | 2.99139469 |
93 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.97042632 |
94 | dopamine biosynthetic process (GO:0042416) | 2.94969561 |
95 | glycine transport (GO:0015816) | 2.94511027 |
96 | central nervous system myelination (GO:0022010) | 2.93634293 |
97 | axon ensheathment in central nervous system (GO:0032291) | 2.93634293 |
98 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.93385081 |
99 | presynaptic membrane organization (GO:0097090) | 2.93029799 |
100 | auditory behavior (GO:0031223) | 2.91329040 |
101 | membrane depolarization during action potential (GO:0086010) | 2.91063393 |
102 | positive regulation of synaptic transmission (GO:0050806) | 2.90507719 |
103 | potassium ion homeostasis (GO:0055075) | 2.90402559 |
104 | transmission of nerve impulse (GO:0019226) | 2.89288446 |
105 | cell migration in hindbrain (GO:0021535) | 2.88898114 |
106 | regulation of synaptic transmission (GO:0050804) | 2.88841553 |
107 | membrane depolarization (GO:0051899) | 2.87933967 |
108 | neuromuscular process (GO:0050905) | 2.87915758 |
109 | presynaptic membrane assembly (GO:0097105) | 2.87346500 |
110 | mating behavior (GO:0007617) | 2.85808705 |
111 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.84801859 |
112 | synaptic transmission (GO:0007268) | 2.83710903 |
113 | response to histamine (GO:0034776) | 2.83123493 |
114 | positive regulation of vesicle fusion (GO:0031340) | 2.82641403 |
115 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.82052833 |
116 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.81834839 |
117 | response to insecticide (GO:0017085) | 2.81234044 |
118 | neurofilament cytoskeleton organization (GO:0060052) | 2.80794749 |
119 | postsynaptic membrane organization (GO:0001941) | 2.80779416 |
120 | behavioral fear response (GO:0001662) | 2.79987649 |
121 | behavioral defense response (GO:0002209) | 2.79987649 |
122 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.79673874 |
123 | cerebellar Purkinje cell layer development (GO:0021680) | 2.79647006 |
124 | clathrin coat assembly (GO:0048268) | 2.78978026 |
125 | prepulse inhibition (GO:0060134) | 2.77443757 |
126 | neuromuscular synaptic transmission (GO:0007274) | 2.76997955 |
127 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.76229219 |
128 | adult walking behavior (GO:0007628) | 2.76078035 |
129 | establishment of mitochondrion localization (GO:0051654) | 2.74919375 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.62657998 |
2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.26229019 |
3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.98410605 |
4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.95075735 |
5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.94550876 |
6 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.58589462 |
7 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.58589462 |
8 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.55525976 |
9 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.50141959 |
10 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.43936747 |
11 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.43244497 |
12 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.41657134 |
13 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.40333734 |
14 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.36791736 |
15 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.35309975 |
16 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.24761246 |
17 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.24044138 |
18 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.19128191 |
19 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.13186862 |
20 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.11711819 |
21 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.08865962 |
22 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.08349766 |
23 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.05594912 |
24 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.03738601 |
25 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.02176694 |
26 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.01528464 |
27 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.97765979 |
28 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.93092173 |
29 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.90172266 |
30 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.88120056 |
31 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.84044338 |
32 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.75067435 |
33 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.72540802 |
34 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.71843915 |
35 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.71616378 |
36 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.67988442 |
37 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.66522328 |
38 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.63274752 |
39 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.54222994 |
40 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.44672918 |
41 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.43670663 |
42 | * SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.43117651 |
43 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.39689589 |
44 | P300_19829295_ChIP-Seq_ESCs_Human | 1.39468432 |
45 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.37850040 |
46 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.36952389 |
47 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.36573756 |
48 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.35838211 |
49 | AR_25329375_ChIP-Seq_VCAP_Human | 1.35519306 |
50 | * CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.35456885 |
51 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.34937726 |
52 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.32015492 |
53 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.30487203 |
54 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.27955039 |
55 | STAT3_23295773_ChIP-Seq_U87_Human | 1.25164935 |
56 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.24557407 |
57 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.23884085 |
58 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.22869248 |
59 | * AR_19668381_ChIP-Seq_PC3_Human | 1.22637235 |
60 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.22017313 |
61 | TP53_16413492_ChIP-PET_HCT116_Human | 1.21989939 |
62 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.20411469 |
63 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.20174159 |
64 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.20024927 |
65 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.19637724 |
66 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.19595498 |
67 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.19053511 |
68 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.17351677 |
69 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.17197438 |
70 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.16522864 |
71 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.16320206 |
72 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.15331295 |
73 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.15015266 |
74 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.14646230 |
75 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.14008525 |
76 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.13869883 |
77 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.13804194 |
78 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.13788688 |
79 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.13196078 |
80 | FUS_26573619_Chip-Seq_HEK293_Human | 1.13001685 |
81 | KDM2B_26808549_Chip-Seq_K562_Human | 1.12907525 |
82 | RXR_22108803_ChIP-Seq_LS180_Human | 1.12820953 |
83 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.12760924 |
84 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.11629489 |
85 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.11269666 |
86 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.10771886 |
87 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.10607734 |
88 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.10337612 |
89 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.10337612 |
90 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.09424158 |
91 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.09114601 |
92 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.09113015 |
93 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.08312921 |
94 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.07985896 |
95 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.06524604 |
96 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.04266262 |
97 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.03977762 |
98 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.02879973 |
99 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.02775960 |
100 | TCF4_23295773_ChIP-Seq_U87_Human | 1.01425481 |
101 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.00316360 |
102 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.99892937 |
103 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.99799536 |
104 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.99799536 |
105 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.99450399 |
106 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.99225289 |
107 | STAT3_18555785_ChIP-Seq_MESCs_Mouse | 0.98847665 |
108 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.98527315 |
109 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.97847014 |
110 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.97344658 |
111 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.97019051 |
112 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.96830732 |
113 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.96716291 |
114 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.96490761 |
115 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.96380633 |
116 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.96135643 |
117 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.95894618 |
118 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.94869099 |
119 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.94687208 |
120 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.93294898 |
121 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.92770602 |
122 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.92023059 |
123 | JUN_21703547_ChIP-Seq_K562_Human | 0.91900638 |
124 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.91431789 |
125 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.84896538 |
126 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.84895043 |
127 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82241195 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0004859_abnormal_synaptic_plasticity | 6.80470821 |
2 | MP0003880_abnormal_central_pattern | 5.10859963 |
3 | MP0003635_abnormal_synaptic_transmissio | 4.22747541 |
4 | MP0004270_analgesia | 3.76656957 |
5 | MP0001968_abnormal_touch/_nociception | 3.38594520 |
6 | MP0002063_abnormal_learning/memory/cond | 3.32100306 |
7 | MP0009745_abnormal_behavioral_response | 3.31121454 |
8 | MP0002064_seizures | 3.09169330 |
9 | MP0009046_muscle_twitch | 3.03327106 |
10 | MP0002736_abnormal_nociception_after | 2.76818759 |
11 | MP0002572_abnormal_emotion/affect_behav | 2.66188272 |
12 | MP0002734_abnormal_mechanical_nocicepti | 2.61718795 |
13 | MP0005423_abnormal_somatic_nervous | 2.45680343 |
14 | MP0002822_catalepsy | 2.43843962 |
15 | MP0002735_abnormal_chemical_nociception | 2.39963992 |
16 | MP0002272_abnormal_nervous_system | 2.37182409 |
17 | MP0001501_abnormal_sleep_pattern | 2.30608832 |
18 | MP0001486_abnormal_startle_reflex | 2.29607666 |
19 | MP0001440_abnormal_grooming_behavior | 2.25594745 |
20 | MP0006276_abnormal_autonomic_nervous | 2.15468421 |
21 | MP0002733_abnormal_thermal_nociception | 2.14892347 |
22 | MP0003329_amyloid_beta_deposits | 2.03548442 |
23 | MP0003122_maternal_imprinting | 2.03468938 |
24 | MP0001970_abnormal_pain_threshold | 2.00541317 |
25 | * MP0002067_abnormal_sensory_capabilities | 1.97309932 |
26 | MP0004858_abnormal_nervous_system | 1.89337669 |
27 | MP0002909_abnormal_adrenal_gland | 1.88961960 |
28 | MP0009780_abnormal_chondrocyte_physiolo | 1.88637353 |
29 | MP0002184_abnormal_innervation | 1.86200427 |
30 | MP0004811_abnormal_neuron_physiology | 1.84368656 |
31 | MP0004924_abnormal_behavior | 1.79544267 |
32 | MP0005386_behavior/neurological_phenoty | 1.79544267 |
33 | MP0002557_abnormal_social/conspecific_i | 1.71204203 |
34 | MP0008569_lethality_at_weaning | 1.66382814 |
35 | MP0010234_abnormal_vibrissa_follicle | 1.64654247 |
36 | MP0005645_abnormal_hypothalamus_physiol | 1.61181068 |
37 | MP0003879_abnormal_hair_cell | 1.61082664 |
38 | * MP0000778_abnormal_nervous_system | 1.60532849 |
39 | MP0000955_abnormal_spinal_cord | 1.52733884 |
40 | MP0003890_abnormal_embryonic-extraembry | 1.52447291 |
41 | MP0005409_darkened_coat_color | 1.50340695 |
42 | MP0001984_abnormal_olfaction | 1.48179160 |
43 | MP0003787_abnormal_imprinting | 1.46292185 |
44 | MP0008877_abnormal_DNA_methylation | 1.44845913 |
45 | MP0003183_abnormal_peptide_metabolism | 1.43082058 |
46 | * MP0002066_abnormal_motor_capabilities/c | 1.37373479 |
47 | MP0000579_abnormal_nail_morphology | 1.37010300 |
48 | MP0000751_myopathy | 1.32967414 |
49 | MP0003633_abnormal_nervous_system | 1.32728497 |
50 | MP0005646_abnormal_pituitary_gland | 1.29803932 |
51 | * MP0002882_abnormal_neuron_morphology | 1.28311176 |
52 | MP0008260_abnormal_autophagy | 1.27971999 |
53 | MP0001529_abnormal_vocalization | 1.25226701 |
54 | MP0000569_abnormal_digit_pigmentation | 1.18022919 |
55 | MP0004885_abnormal_endolymph | 1.17058622 |
56 | MP0004142_abnormal_muscle_tone | 1.15293553 |
57 | MP0004145_abnormal_muscle_electrophysio | 1.13322604 |
58 | MP0003123_paternal_imprinting | 1.12070336 |
59 | MP0003631_nervous_system_phenotype | 1.10837470 |
60 | MP0008961_abnormal_basal_metabolism | 1.10181774 |
61 | MP0001502_abnormal_circadian_rhythm | 1.09659535 |
62 | MP0000566_synostosis | 1.04951564 |
63 | MP0001905_abnormal_dopamine_level | 1.02137984 |
64 | * MP0002152_abnormal_brain_morphology | 1.01048904 |
65 | MP0002089_abnormal_postnatal_growth/wei | 1.00682743 |
66 | MP0005187_abnormal_penis_morphology | 0.98800390 |
67 | MP0008874_decreased_physiological_sensi | 0.95888642 |
68 | MP0000604_amyloidosis | 0.95192143 |
69 | MP0002837_dystrophic_cardiac_calcinosis | 0.93862430 |
70 | MP0001177_atelectasis | 0.93518157 |
71 | MP0004484_altered_response_of | 0.86140392 |
72 | MP0004510_myositis | 0.85806806 |
73 | MP0003121_genomic_imprinting | 0.85740214 |
74 | MP0003075_altered_response_to | 0.84913229 |
75 | MP0002069_abnormal_eating/drinking_beha | 0.83673245 |
76 | MP0010386_abnormal_urinary_bladder | 0.83573112 |
77 | MP0005167_abnormal_blood-brain_barrier | 0.82189090 |
78 | MP0008872_abnormal_physiological_respon | 0.81981793 |
79 | MP0003283_abnormal_digestive_organ | 0.81104898 |
80 | MP0004742_abnormal_vestibular_system | 0.78966908 |
81 | MP0001299_abnormal_eye_distance/ | 0.78937528 |
82 | MP0005535_abnormal_body_temperature | 0.78569986 |
83 | MP0004215_abnormal_myocardial_fiber | 0.76615933 |
84 | MP0000749_muscle_degeneration | 0.75322201 |
85 | MP0003632_abnormal_nervous_system | 0.75043329 |
86 | MP0004233_abnormal_muscle_weight | 0.73948703 |
87 | MP0002229_neurodegeneration | 0.73233494 |
88 | MP0008057_abnormal_DNA_replication | 0.70948901 |
89 | MP0005248_abnormal_Harderian_gland | 0.69923141 |
90 | MP0000747_muscle_weakness | 0.69885849 |
91 | MP0000013_abnormal_adipose_tissue | 0.69763149 |
92 | MP0004085_abnormal_heartbeat | 0.68523902 |
93 | MP0001346_abnormal_lacrimal_gland | 0.68106957 |
94 | MP0001348_abnormal_lacrimal_gland | 0.67436681 |
95 | MP0003634_abnormal_glial_cell | 0.66581257 |
96 | MP0003646_muscle_fatigue | 0.66290347 |
97 | MP0003690_abnormal_glial_cell | 0.64383980 |
98 | MP0004130_abnormal_muscle_cell | 0.64057591 |
99 | MP0005499_abnormal_olfactory_system | 0.62670207 |
100 | MP0005394_taste/olfaction_phenotype | 0.62670207 |
101 | MP0001485_abnormal_pinna_reflex | 0.62416849 |
102 | MP0005623_abnormal_meninges_morphology | 0.62113723 |
103 | MP0005388_respiratory_system_phenotype | 0.60532918 |
104 | MP0002133_abnormal_respiratory_system | 0.60532918 |
105 | MP0001188_hyperpigmentation | 0.60270448 |
106 | MP0001963_abnormal_hearing_physiology | 0.59990959 |
107 | * MP0010770_preweaning_lethality | 0.57373439 |
108 | * MP0002082_postnatal_lethality | 0.57373439 |
109 | MP0000537_abnormal_urethra_morphology | 0.57361433 |
110 | MP0001664_abnormal_digestion | 0.56696263 |
111 | MP0002332_abnormal_exercise_endurance | 0.56258300 |
112 | MP0002081_perinatal_lethality | 0.55677408 |
113 | MP0001943_abnormal_respiration | 0.54757520 |
114 | MP0002090_abnormal_vision | 0.53966408 |
115 | MP0005166_decreased_susceptibility_to | 0.53665150 |
116 | MP0002752_abnormal_somatic_nervous | 0.53432088 |
117 | MP0000920_abnormal_myelination | 0.52796740 |
118 | MP0003137_abnormal_impulse_conducting | 0.50694299 |
119 | MP0000631_abnormal_neuroendocrine_gland | 0.50220765 |
120 | * MP0003861_abnormal_nervous_system | 0.48578022 |
121 | * MP0010769_abnormal_survival | 0.46325754 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Focal motor seizures (HP:0011153) | 7.84347269 |
2 | Myokymia (HP:0002411) | 6.32602292 |
3 | Focal seizures (HP:0007359) | 5.89114152 |
4 | Visual hallucinations (HP:0002367) | 5.78401915 |
5 | Atonic seizures (HP:0010819) | 4.57085051 |
6 | Absence seizures (HP:0002121) | 4.51263974 |
7 | Epileptic encephalopathy (HP:0200134) | 4.31441970 |
8 | Febrile seizures (HP:0002373) | 4.24417485 |
9 | Progressive cerebellar ataxia (HP:0002073) | 4.20878116 |
10 | Generalized tonic-clonic seizures (HP:0002069) | 4.07232058 |
11 | Dialeptic seizures (HP:0011146) | 4.01138706 |
12 | Action tremor (HP:0002345) | 3.85189958 |
13 | Supranuclear gaze palsy (HP:0000605) | 3.66354950 |
14 | Depression (HP:0000716) | 3.30844149 |
15 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.28791648 |
16 | Ankle clonus (HP:0011448) | 3.26853545 |
17 | Poor eye contact (HP:0000817) | 3.24979427 |
18 | Papilledema (HP:0001085) | 3.12955185 |
19 | Abnormal eating behavior (HP:0100738) | 3.12480706 |
20 | Mutism (HP:0002300) | 3.12075582 |
21 | Broad-based gait (HP:0002136) | 3.07226362 |
22 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.03662039 |
23 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.03411072 |
24 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.03411072 |
25 | Impaired social interactions (HP:0000735) | 3.01131966 |
26 | Abnormal social behavior (HP:0012433) | 3.01131966 |
27 | Dysdiadochokinesis (HP:0002075) | 2.98759623 |
28 | Progressive inability to walk (HP:0002505) | 2.97889527 |
29 | Urinary urgency (HP:0000012) | 2.95240668 |
30 | Truncal ataxia (HP:0002078) | 2.90558412 |
31 | Postural instability (HP:0002172) | 2.87765505 |
32 | Genetic anticipation (HP:0003743) | 2.86407995 |
33 | Termporal pattern (HP:0011008) | 2.83634840 |
34 | Insidious onset (HP:0003587) | 2.83634840 |
35 | Dysmetria (HP:0001310) | 2.81512965 |
36 | Gaze-evoked nystagmus (HP:0000640) | 2.76337226 |
37 | Amblyopia (HP:0000646) | 2.73396055 |
38 | Anxiety (HP:0000739) | 2.68180161 |
39 | Abnormality of the lower motor neuron (HP:0002366) | 2.61816124 |
40 | Drooling (HP:0002307) | 2.60630163 |
41 | Excessive salivation (HP:0003781) | 2.60630163 |
42 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.57667557 |
43 | Failure to thrive in infancy (HP:0001531) | 2.54671700 |
44 | Hyperventilation (HP:0002883) | 2.54468589 |
45 | Ventricular fibrillation (HP:0001663) | 2.50924770 |
46 | Fetal akinesia sequence (HP:0001989) | 2.50215985 |
47 | Polyphagia (HP:0002591) | 2.47962131 |
48 | Papillary thyroid carcinoma (HP:0002895) | 2.46496868 |
49 | Limb dystonia (HP:0002451) | 2.45146921 |
50 | Torticollis (HP:0000473) | 2.42421007 |
51 | Bradykinesia (HP:0002067) | 2.41738995 |
52 | Impaired smooth pursuit (HP:0007772) | 2.40030585 |
53 | Pheochromocytoma (HP:0002666) | 2.37718124 |
54 | Scanning speech (HP:0002168) | 2.35238989 |
55 | Status epilepticus (HP:0002133) | 2.35105536 |
56 | Spastic gait (HP:0002064) | 2.31959985 |
57 | Cerebral inclusion bodies (HP:0100314) | 2.31227935 |
58 | Tetraplegia (HP:0002445) | 2.30714419 |
59 | Difficulty running (HP:0009046) | 2.30027153 |
60 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.29139877 |
61 | Generalized myoclonic seizures (HP:0002123) | 2.27676709 |
62 | Epileptiform EEG discharges (HP:0011182) | 2.27234045 |
63 | Dysmetric saccades (HP:0000641) | 2.25727433 |
64 | Clonus (HP:0002169) | 2.25087133 |
65 | Hemiparesis (HP:0001269) | 2.21654280 |
66 | Diplopia (HP:0000651) | 2.20560564 |
67 | Abnormality of binocular vision (HP:0011514) | 2.20560564 |
68 | Aplasia involving bones of the extremities (HP:0009825) | 2.18722570 |
69 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.18722570 |
70 | Aplasia of the phalanges of the hand (HP:0009802) | 2.18722570 |
71 | EEG with generalized epileptiform discharges (HP:0011198) | 2.18618698 |
72 | Focal dystonia (HP:0004373) | 2.18402063 |
73 | Agitation (HP:0000713) | 2.18330277 |
74 | Stereotypic behavior (HP:0000733) | 2.18062669 |
75 | Hemiplegia (HP:0002301) | 2.17242043 |
76 | Intention tremor (HP:0002080) | 2.17195190 |
77 | Impaired vibratory sensation (HP:0002495) | 2.14456710 |
78 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.14160887 |
79 | Sleep apnea (HP:0010535) | 2.14070319 |
80 | Absent speech (HP:0001344) | 2.13336511 |
81 | Inability to walk (HP:0002540) | 2.09662484 |
82 | Aqueductal stenosis (HP:0002410) | 2.07828016 |
83 | Bundle branch block (HP:0011710) | 2.07825331 |
84 | Hypsarrhythmia (HP:0002521) | 2.07509863 |
85 | Inappropriate behavior (HP:0000719) | 2.06084908 |
86 | Hyporeflexia of lower limbs (HP:0002600) | 2.05616724 |
87 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.05295090 |
88 | Delusions (HP:0000746) | 2.04204497 |
89 | Lower limb asymmetry (HP:0100559) | 2.03054568 |
90 | Megalencephaly (HP:0001355) | 2.01743379 |
91 | Lower limb muscle weakness (HP:0007340) | 2.01653522 |
92 | Apathy (HP:0000741) | 2.01562536 |
93 | Split foot (HP:0001839) | 2.00813210 |
94 | Neuroendocrine neoplasm (HP:0100634) | 2.00730467 |
95 | Shoulder girdle muscle weakness (HP:0003547) | 2.00066608 |
96 | Rapidly progressive (HP:0003678) | 1.99173446 |
97 | Hypoventilation (HP:0002791) | 1.98844246 |
98 | Thickened helices (HP:0000391) | 1.98556513 |
99 | Decreased motor nerve conduction velocity (HP:0003431) | 1.98033898 |
100 | Amyotrophic lateral sclerosis (HP:0007354) | 1.96055296 |
101 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.96030063 |
102 | Gait ataxia (HP:0002066) | 1.93601187 |
103 | Pointed chin (HP:0000307) | 1.92206454 |
104 | Lower limb amyotrophy (HP:0007210) | 1.91996187 |
105 | Craniofacial dystonia (HP:0012179) | 1.91596722 |
106 | Paraplegia (HP:0010550) | 1.91465676 |
107 | Hammertoe (HP:0001765) | 1.91273101 |
108 | Peripheral hypomyelination (HP:0007182) | 1.89609163 |
109 | Foot dorsiflexor weakness (HP:0009027) | 1.89042162 |
110 | Neurofibrillary tangles (HP:0002185) | 1.88100274 |
111 | Psychosis (HP:0000709) | 1.87098996 |
112 | Ankyloglossia (HP:0010296) | 1.86663647 |
113 | Blue irides (HP:0000635) | 1.86527373 |
114 | Abnormality of the corticospinal tract (HP:0002492) | 1.84588653 |
115 | Incomplete penetrance (HP:0003829) | 1.84535035 |
116 | Spastic paraplegia (HP:0001258) | 1.84512279 |
117 | Rigidity (HP:0002063) | 1.83815894 |
118 | Agnosia (HP:0010524) | 1.82113718 |
119 | Intellectual disability, profound (HP:0002187) | 1.82084939 |
120 | Spastic tetraparesis (HP:0001285) | 1.80886439 |
121 | Distal sensory impairment (HP:0002936) | 1.79982796 |
122 | Neuronal loss in central nervous system (HP:0002529) | 1.79908391 |
123 | Slow saccadic eye movements (HP:0000514) | 1.78998558 |
124 | Abnormality of the foot musculature (HP:0001436) | 1.78765750 |
125 | Diminished motivation (HP:0000745) | 1.78465853 |
126 | Resting tremor (HP:0002322) | 1.76975847 |
127 | Abnormality of saccadic eye movements (HP:0000570) | 1.76466587 |
128 | Abnormality of salivation (HP:0100755) | 1.75859050 |
129 | Akinesia (HP:0002304) | 1.75606631 |
130 | Dysphonia (HP:0001618) | 1.75538051 |
131 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.74990570 |
132 | Subacute progressive viral hepatitis (HP:0006572) | 1.73267938 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MAP3K9 | 4.72618956 |
2 | NTRK3 | 4.51962180 |
3 | MAP3K4 | 3.49329319 |
4 | EPHA4 | 3.31244269 |
5 | MINK1 | 3.19484794 |
6 | KSR2 | 2.86065725 |
7 | MARK1 | 2.69644509 |
8 | MAP2K7 | 2.68613722 |
9 | PAK6 | 2.32391153 |
10 | RIPK4 | 2.26595156 |
11 | * MAP2K4 | 2.13968366 |
12 | KSR1 | 2.10454454 |
13 | LATS2 | 1.96347760 |
14 | DAPK2 | 1.94764821 |
15 | NTRK2 | 1.91617116 |
16 | CAMKK1 | 1.73398138 |
17 | MAP3K13 | 1.64150078 |
18 | PRKD3 | 1.59953917 |
19 | NTRK1 | 1.59786260 |
20 | ARAF | 1.56965492 |
21 | CDK19 | 1.49380439 |
22 | PLK2 | 1.47007373 |
23 | CDK5 | 1.43261324 |
24 | STK38 | 1.33845146 |
25 | MAP3K2 | 1.26734384 |
26 | GRK5 | 1.26387025 |
27 | DAPK1 | 1.22845341 |
28 | TAOK1 | 1.22636999 |
29 | RET | 1.22405037 |
30 | TYRO3 | 1.17435785 |
31 | PNCK | 1.14154043 |
32 | MAPK13 | 1.11784917 |
33 | TNIK | 1.11313207 |
34 | RAF1 | 1.08588153 |
35 | PAK3 | 1.06701335 |
36 | CASK | 1.05314609 |
37 | OBSCN | 1.04640478 |
38 | PRKCG | 1.00032018 |
39 | SIK2 | 0.94472533 |
40 | FER | 0.94352609 |
41 | FES | 0.94300535 |
42 | CDK18 | 0.93197087 |
43 | CDK14 | 0.92722311 |
44 | PHKG2 | 0.91366239 |
45 | PHKG1 | 0.91366239 |
46 | MAP3K6 | 0.89840358 |
47 | CDK15 | 0.89012264 |
48 | STK11 | 0.88370729 |
49 | CAMK2A | 0.88369105 |
50 | NEK1 | 0.86673811 |
51 | LMTK2 | 0.85911342 |
52 | ALK | 0.85879305 |
53 | WNK3 | 0.84803633 |
54 | UHMK1 | 0.84257243 |
55 | CAMKK2 | 0.79313910 |
56 | CDK11A | 0.75983028 |
57 | STK39 | 0.74176467 |
58 | CSNK1G2 | 0.74156014 |
59 | CAMK1 | 0.74051969 |
60 | PRPF4B | 0.73272318 |
61 | CAMK4 | 0.72807635 |
62 | PRKCH | 0.72146959 |
63 | SCYL2 | 0.71673166 |
64 | SIK3 | 0.71066850 |
65 | PDK1 | 0.69340466 |
66 | YES1 | 0.69295311 |
67 | DYRK2 | 0.68390377 |
68 | BCR | 0.67095039 |
69 | RIPK1 | 0.66964324 |
70 | TSSK6 | 0.66889634 |
71 | AKT3 | 0.65504326 |
72 | WNK1 | 0.65013664 |
73 | PTK2B | 0.64574650 |
74 | PDGFRA | 0.63744139 |
75 | PDPK1 | 0.62631122 |
76 | MAP2K1 | 0.61874284 |
77 | SGK494 | 0.61727755 |
78 | SGK223 | 0.61727755 |
79 | SGK2 | 0.60590961 |
80 | FGFR2 | 0.60533814 |
81 | PINK1 | 0.58699924 |
82 | BMPR2 | 0.57909704 |
83 | SGK3 | 0.57311443 |
84 | LIMK1 | 0.57099547 |
85 | * SGK1 | 0.54642433 |
86 | BRAF | 0.54197815 |
87 | DYRK1B | 0.52769268 |
88 | TNK2 | 0.52580679 |
89 | MAPK12 | 0.52334368 |
90 | NEK6 | 0.52216852 |
91 | CAMK2B | 0.51744500 |
92 | DMPK | 0.51731274 |
93 | ERBB3 | 0.51132362 |
94 | MAPK10 | 0.49409783 |
95 | MAP3K7 | 0.46834770 |
96 | CAMK1D | 0.46725771 |
97 | RPS6KA3 | 0.45307760 |
98 | CSNK1G1 | 0.44820454 |
99 | FYN | 0.44396322 |
100 | * MAP3K1 | 0.44289788 |
101 | DYRK1A | 0.43836236 |
102 | PRKCZ | 0.43803066 |
103 | CSNK1A1L | 0.42668537 |
104 | NME1 | 0.42133669 |
105 | ROCK2 | 0.41699552 |
106 | MAP2K3 | 0.41415365 |
107 | BMX | 0.40469884 |
108 | MOS | 0.40327238 |
109 | MAPKAPK5 | 0.39589797 |
110 | PRKG1 | 0.39279112 |
111 | RPS6KB1 | 0.38789066 |
112 | * MAP3K12 | 0.38698019 |
113 | BRD4 | 0.37283901 |
114 | MARK2 | 0.37129289 |
115 | CAMK2G | 0.36397833 |
116 | FGR | 0.35953227 |
117 | OXSR1 | 0.35159099 |
118 | CAMK1G | 0.34194207 |
119 | PRKCE | 0.33587185 |
120 | CDC42BPA | 0.33264767 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.39072766 |
2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.27949703 |
3 | Long-term potentiation_Homo sapiens_hsa04720 | 2.61907778 |
4 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.41495053 |
5 | Olfactory transduction_Homo sapiens_hsa04740 | 2.40759343 |
6 | GABAergic synapse_Homo sapiens_hsa04727 | 2.40336685 |
7 | Circadian entrainment_Homo sapiens_hsa04713 | 2.37912105 |
8 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.28638412 |
9 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.28078229 |
10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.17447243 |
11 | Morphine addiction_Homo sapiens_hsa05032 | 2.12905370 |
12 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.07018850 |
13 | Salivary secretion_Homo sapiens_hsa04970 | 1.92384922 |
14 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.81138768 |
15 | Long-term depression_Homo sapiens_hsa04730 | 1.75275119 |
16 | Insulin secretion_Homo sapiens_hsa04911 | 1.75018891 |
17 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.72139960 |
18 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.62877979 |
19 | Renin secretion_Homo sapiens_hsa04924 | 1.61019470 |
20 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.60877146 |
21 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.60465676 |
22 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.60383825 |
23 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.53546591 |
24 | * GnRH signaling pathway_Homo sapiens_hsa04912 | 1.53251703 |
25 | Cocaine addiction_Homo sapiens_hsa05030 | 1.47413115 |
26 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.39856572 |
27 | Taste transduction_Homo sapiens_hsa04742 | 1.38634411 |
28 | Gap junction_Homo sapiens_hsa04540 | 1.38344520 |
29 | Glioma_Homo sapiens_hsa05214 | 1.35715380 |
30 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.35636929 |
31 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.34183254 |
32 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.26885800 |
33 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.23140095 |
34 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.16543706 |
35 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.15487309 |
36 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.13859619 |
37 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.13182132 |
38 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.12835513 |
39 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.11683640 |
40 | * ErbB signaling pathway_Homo sapiens_hsa04012 | 1.10964008 |
41 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.09131840 |
42 | Axon guidance_Homo sapiens_hsa04360 | 1.07623168 |
43 | Melanogenesis_Homo sapiens_hsa04916 | 1.05274730 |
44 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.00005693 |
45 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.93668901 |
46 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.88471621 |
47 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.88372850 |
48 | * Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.86661463 |
49 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.86413036 |
50 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.85859060 |
51 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.85224444 |
52 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.81774738 |
53 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.81127247 |
54 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.79542809 |
55 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.76734456 |
56 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.76577102 |
57 | * MAPK signaling pathway_Homo sapiens_hsa04010 | 0.75718061 |
58 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.74698039 |
59 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.73928390 |
60 | Tight junction_Homo sapiens_hsa04530 | 0.72922603 |
61 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.72848476 |
62 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.70356412 |
63 | Adherens junction_Homo sapiens_hsa04520 | 0.69237336 |
64 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.68001919 |
65 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.67265849 |
66 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.65478088 |
67 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.63760868 |
68 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.63356007 |
69 | Endometrial cancer_Homo sapiens_hsa05213 | 0.63194704 |
70 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.62745882 |
71 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.61838036 |
72 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.60715421 |
73 | Alcoholism_Homo sapiens_hsa05034 | 0.60620628 |
74 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.59881795 |
75 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.59391535 |
76 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.59251149 |
77 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.58455539 |
78 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.57725606 |
79 | Endocytosis_Homo sapiens_hsa04144 | 0.57505165 |
80 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.57407644 |
81 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.56767910 |
82 | Prion diseases_Homo sapiens_hsa05020 | 0.56306093 |
83 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.55575951 |
84 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.55072024 |
85 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.53178412 |
86 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.52986637 |
87 | * Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.52892420 |
88 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.51803156 |
89 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.51429638 |
90 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.49167745 |
91 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.49161553 |
92 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.48751223 |
93 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.47790922 |
94 | Bile secretion_Homo sapiens_hsa04976 | 0.46794596 |
95 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.46629014 |
96 | Amoebiasis_Homo sapiens_hsa05146 | 0.45202409 |
97 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.44850001 |
98 | Salmonella infection_Homo sapiens_hsa05132 | 0.44257080 |
99 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.43762994 |
100 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.42812026 |
101 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.42797207 |
102 | Phototransduction_Homo sapiens_hsa04744 | 0.41824481 |
103 | Colorectal cancer_Homo sapiens_hsa05210 | 0.41267680 |
104 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.40107898 |
105 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.40010551 |
106 | Circadian rhythm_Homo sapiens_hsa04710 | 0.37867764 |
107 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.37710241 |
108 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.35158574 |
109 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.35078468 |
110 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.34790918 |
111 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.33826803 |
112 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.33547363 |
113 | Platelet activation_Homo sapiens_hsa04611 | 0.33028841 |
114 | * Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.33011927 |